158 related articles for article (PubMed ID: 35880064)
1. Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination.
Panizo N; Albert E; Giménez-Civera E; Puchades MJ; D'Marco L; Gandía-Salmerón L; Giménez E; Torre I; Sancho A; Gavela E; Gonzalez-Rico M; Montomoli M; Perez-Baylach CM; Bonilla B; Solano C; Alvarado MF; Torregrosa I; Alcaraz MJ; Górriz JL; Navarro D
Clin Kidney J; 2022 Aug; 15(8):1562-1573. PubMed ID: 35880064
[TBL] [Abstract][Full Text] [Related]
2. Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation.
Iwabuchi R; Harada M; Yamada A; Aomura D; Yamada Y; Sonoda K; Nakazawa H; Sakai K; Mizukami E; Hashimoto K; Kamijo Y
Clin Exp Nephrol; 2023 Aug; 27(8):660-671. PubMed ID: 37095343
[TBL] [Abstract][Full Text] [Related]
3. Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.
Quiroga B; Soler MJ; Ortiz A; Martínez Vaquera S; Jarava Mantecón CJ; Useche G; Sánchez Márquez MG; Carnerero M; Jaldo Rodríguez MT; Muñoz Ramos P; Ruiz San Millán JC; Toapanta N; Gracia-Iguacel C; Aguilar Cervera MC; Balibrea Lara N; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
Nephrol Dial Transplant; 2022 Sep; 37(10):1868-1878. PubMed ID: 34788858
[TBL] [Abstract][Full Text] [Related]
4. Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study.
Quiroga B; Soler MJ; Ortiz A; Jarava Mantecón CJ; Gomes Pérez VO; Bordils A; Lacueva J; Marin Franco AJ; Delgado Conde P; Muñoz Ramos P; Calderón González C; Cazorla López JM; Sanchez-Rodriguez J; Sánchez Horrillo A; Monzón Vázquez TR; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
Nephrol Dial Transplant; 2023 Mar; 38(4):969-981. PubMed ID: 36423334
[TBL] [Abstract][Full Text] [Related]
5. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls.
Simon B; Rubey H; Treipl A; Gromann M; Hemedi B; Zehetmayer S; Kirsch B
Nephrol Dial Transplant; 2021 Aug; 36(9):1709-1716. PubMed ID: 33999200
[TBL] [Abstract][Full Text] [Related]
6. Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring.
Crespo M; Barrilado-Jackson A; Padilla E; Eguía J; Echeverria-Esnal D; Cao H; Faura A; Folgueiras M; Solà-Porta E; Pascual S; Barbosa F; Hurtado S; Ribera L; Río-No L; Pérez-Sáez MJ; Redondo-Pachón D; Pascual J
Am J Transplant; 2022 Mar; 22(3):786-800. PubMed ID: 34551187
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Bruminhent J; Setthaudom C; Kitpermkiat R; Kiertiburanakul S; Malathum K; Assanatham M; Nongnuch A; Phuphuakrat A; Chaumdee P; Janphram C; Thotsiri S; Chuengsaman P; Boongird S
Sci Rep; 2022 Mar; 12(1):3587. PubMed ID: 35246578
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination.
Gonzalez-Perez M; Baranda J; Berges-Buxeda MJ; Conde P; Pérez-Olmeda M; Lozano-Ojalvo D; Cámara C; Del Rosario Llópez-Carratalá M; Gonzalez-Parra E; Portolés P; Ortiz A; Portoles J; Ochando J
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111331
[TBL] [Abstract][Full Text] [Related]
9. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A
Front Immunol; 2021; 12():780594. PubMed ID: 34925359
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant.
Seija M; Rammauro F; Santiago J; Orihuela N; Zulberti C; Machado D; Recalde C; Noboa J; Frantchez V; Astesiano R; Yandián F; Guerisoli A; Morra Á; Cassinelli D; Coelho C; de Aramburu B; González-Severgnini P; Moreno R; Pippolo A; López G; Lemos M; Somariva L; López E; Fumero S; Orihuela C; Rodríguez R; Acuña G; Rabaza V; Perg N; Cordero R; Reisfeld C; Olivera P; Montero P; Nogueira C; Nalerio C; Orihuela S; Curi L; Burgstaller E; Noboa O; Pritsch O; Nin M; Bianchi S
Clin Kidney J; 2022 Mar; 15(3):527-533. PubMed ID: 35198159
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
Bensouna I; Caudwell V; Kubab S; Acquaviva S; Pardon A; Vittoz N; Bozman DF; Hanafi L; Faucon AL; Housset P
Am J Kidney Dis; 2022 Feb; 79(2):185-192.e1. PubMed ID: 34508833
[TBL] [Abstract][Full Text] [Related]
12. Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF; Messchendorp AL; de Vries RD; Baan CC; van Baarle D; van Binnendijk R; Diavatopoulos DA; Geers D; Schmitz KS; GeurtsvanKessel CH; den Hartog G; Kho MML; Koopmans MPG; van der Molen RG; Remmerswaal EBM; Rots N; Gansevoort RT; Bemelman FJ; Hilbrands LB; Reinders MEJ;
Clin Infect Dis; 2023 Feb; 76(3):e188-e199. PubMed ID: 35796536
[TBL] [Abstract][Full Text] [Related]
13. Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose.
Angel-Korman A; Peres E; Bryk G; Lustig Y; Indenbaum V; Amit S; Rappoport V; Katzir Z; Yagil Y; Iaina NL; Leiba A; Brosh-Nissimov T
Clin Kidney J; 2022 Feb; 15(2):226-234. PubMed ID: 35140934
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.
Hamaya T; Hatakeyama S; Yoneyama T; Tobisawa Y; Kodama H; Fujita T; Murakami R; Fujita N; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Saitoh H; Narumi S; Tomita H; Ohyama C
Sci Rep; 2022 Apr; 12(1):5876. PubMed ID: 35393481
[TBL] [Abstract][Full Text] [Related]
15. Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients.
Knell AI; Böhm AK; Jäger M; Kerschbaum J; Engl S; Rudnicki M; Buchwinkler L; Bellmann-Weiler R; Posch W; Weiss G
Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37512928
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
[TBL] [Abstract][Full Text] [Related]
17. The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients.
Duni A; Markopoulos GS; Mallioras I; Pappas H; Pappas E; Koutlas V; Tzalavra E; Baxevanos G; Priska S; Gartzonika K; Mitsis M; Dounousi E
Front Immunol; 2021; 12():760249. PubMed ID: 34925330
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
19. B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
Iannetta M; Landi D; Cola G; Campogiani L; Malagnino V; Teti E; Coppola L; Di Lorenzo A; Fraboni D; Buccisano F; Grelli S; Mozzani M; Zingaropoli MA; Ciardi MR; Nisini R; Bernardini S; Andreoni M; Marfia GA; Sarmati L
Front Immunol; 2021; 12():796482. PubMed ID: 35111162
[TBL] [Abstract][Full Text] [Related]
20. B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response.
Schuller M; Pfeifer V; Kirsch AH; Klötzer KA; Mooslechner AA; Rosenkranz AR; Stiegler P; Schemmer P; Sourij H; Eller P; Prietl B; Eller K
Front Med (Lausanne); 2022; 9():818882. PubMed ID: 35187002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
